Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

Lawrence S. Phillips*, George Grunberger, Elizabeth Miller, Rita Patwardhan, Elizabeth B. Rappaport, Alan Salzman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

277 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science